| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.2 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.072 | 0.2 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.2 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |